Rod and Cone Dystrophy is a progressive, hereditary retinal disorder that impacts both the rod cells, which govern night and peripheral sight, and the cone cells, which govern color perception and central vision. Patients usually notice trouble seeing in dim settings first, followed over time by narrowing peripheral vision and difficulty telling colors apart. India has become a widely trusted destination for **Stem cell therapy for Rod and Cone Dystrophy in Mexico**, though it’s worth understanding that a complete cure for this genetic condition remains an ongoing area of research within medicine.
Advancements in stem cell technology have introduced treatment strategies with genuine relevance to patients affected by inherited photoreceptor disorders. Within **Stem cell therapy for Rod and Cone Dystrophy**, where both rod and cone photoreceptor function decline progressively, this treatment is best framed as a supportive pathway rather than an assured outcome. The goal is to sustain the surviving photoreceptor population and establish conditions that may help slow the pace of retinal decline.
Mesenchymal stem cell injections via the Retro-bulbar route have become a dependable choice for patients with rod-cone disorders, generally requiring one or two sessions to complete. This technique has built a favorable record of supporting the regenerative response of retinal cells impacted by progressive photoreceptor breakdown. Its reach extends to photoreceptor cells, the retinal pigment epithelium, and macular cells, giving the therapy relevance across the different stages of rod and cone dystrophy.
Patients in Mexico managing this inherited disorder can connect with the Eye Stem Cell Center, which brings over 12 years of dedicated experience treating genetic retinal dystrophies. Our team in India carries out a detailed, report-based review of each patient’s case before advising on suitability.
Eye Stem Cell Center is one of the most trusted providers of Stem cell therapy for Rod and Cone Dystrophy in Mexico.

